首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1410093

數位治療市場：2023年至2028年預測

Digital Therapeutics Market - Forecasts from 2023 to 2028

出版日期: 2023年12月18日 | 出版商:

Knowledge Sourcing Intelligence | 英文 146 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計到 2028 年，數位治療市場將達到 189.84 億美元，預測期內複合年成長率為 30.47%。

數位療法是透過數位技術提供的用於治療、管理或預防疾病和病症的治療方法。這些干預措施可以單獨使用或與其他治療方法結合使用，旨在補充或取代傳統醫學。為了鼓勵患者行為改變，DTx 使用行動電話、應用程式、感測器、虛擬實境和物聯網等數位工具。

數位治療市場的成長動力

數位治療市場是由數位化且價格實惠的醫療保健設施、行動裝置的使用增加以及綜合醫療保健系統的興起所推動的。此外，由於全球化的進步和吸煙、不良飲食習慣、缺乏運動和飲酒等生活方式的改變，慢性病的盛行率正在增加。穿戴式裝置和行動裝置是目前正在進行的兩項重大技術突破，它們正在為數位療法的開發和接受創造必要的基礎設施。數位療法引起付款人和雇主的興趣，因為它們在降低醫療成本方面具有成本效益。

慢性疾病患者增加

患有慢性病的患者數量不斷增加是推動數位治療市場成長的主要因素之一。根據國家慢性病預防與健康促進中心的數據，美國十分之四的成年人患有兩種或多種慢性病，十分之六的美國人至少患有一種慢性病。此外，2022 年 2 月，Teladoc Health, Inc. 推出了 Chronic Care Complete，這是一種全面慢性病管理的突破性方法，有望改善患者的治療結果。美國導致死亡和殘疾的主要疾病包括心血管疾病、癌症、糖尿病、慢性腎臟病、肺病和阿茲海默症。

推出數位治療行動應用程式

用於數位治療的尖端行動應用程式的推出預計將在預期的一年中推動數位治療市場的成長。這一成長是由主要行業參與者對監管核准的日益關注所推動的。此外，智慧型手機、智慧醫療設備和雲端基礎的資料平台使得更好的治療和健康監測成為可能。這些因素正在促進數位療法全球市場佔有率的擴大。

數位治療解決方案的採用增加預計將推動市場發展

隨著醫療保健的數位化，數位治療解決方案的採用預計將會成長。例如，2022 年 2 月，DynamiCare Health Inc. 宣布 DCH-001 是一種治療與懷孕和分娩相關的菸草使用障礙的數位療法，獲得美國食品藥物管理局(FDA) 的突破性設備指定。 FDA 也聲稱數位治療解決方案可以幫助消費者做出更明智的健康決策。

日益關注數位健康

數位健康工具透過為許多不同健康領域的消費者提供支持，正在徹底改變消費者的健康和自我護理，預計這將推動數位治療市場的發展。這些技術已經為多個不同健康領域的消費者提供支援。自我護理數位健康療程特別適合用餐和營養、生活方式和壓力管理、健身、心理健康、女性健康、疼痛管理和睡眠等領域。此外，透過利用尖端技術、資料驅動的見解和方便用戶使用的介面，消費者可以在各個領域使用數位健康工具來主動管理他們的健康並改善結果，從而提高和提高滿意度。

北美預計將主導數位治療市場

由於有利的報銷方案強調更好的追蹤和診斷以及透過增加數位醫療產品的利用率來提高生活品質，預計北美數位治療市場將在預測期內顯著擴大。此外，該地區主要企業的新產品發布和併購等策略行動預計將推動市場成長。

主要市場參與者專注於產品創新

由於美國醫療保健系統不斷進行改進以限制成本上漲，並且越來越重視使用以患者為中心的醫療保健模式，數位治療市場佔有率預計將增加。例如，使用智慧型手機管理慢性病的 Kaia Health 於 2021 年 4 月完成了 7,500 萬美元的 C 輪資金籌措。透過為多種疾病（包括糖尿病、氣喘和肥胖症）的治療和管理提供改進的選擇，數位療法的使用預計將成長。

產品創新進一步激發市場活力

預測期內可能推出的大量藥物有利於處方數位治療（PDTx）市場的成長。數位治療也使用 VR 技術以及數位藥物和應用程式。儘管這項技術已經使用了 20 多年，但僅用於治療有限的疾病和專門設施。它已被證明是對 PTSD 進行暴露療法的重要工具。也對其治療精神病、成癮、強迫性精神官能症恐懼症、憂鬱症、焦慮症和飲食障礙疾病的有效性進行了研究。 DTx的VR技術使用戶能夠透過模擬體驗真實場景的同時進行學習。

市場主要發展

2023年2月，ObvioHealth發布了專用位療法（DTx）臨床試驗開發的專有應用程式介面（API）。 2023 年 1 月，專門從事慢性病虛擬管理的醫療保健公司 Omada Health, Inc. 與 Intermountain Healthcare 的價值護理子公司 Castell 合作。 2022 年 9 月，Limbix Health 與洛杉磯兒童醫院 (CHLA) 合作進行了 SparkRx 的研究。在某些醫療環境中表現出憂鬱症徵兆的青少年可能會受益於 SparkRx 的額外藥物治療。

Digital therapeutics are treatments that are delivered via digital technology to treat, manage, or prevent a disease or medical condition. These interventions can be used alone or in combination with other therapies, and they are intended to supplement or replace traditional medical treatments. To encourage patients to change their behaviour, DTx employs digital tools including mobile phones, apps, sensors, virtual reality, the Internet of Things, and other tools.

Growth drivers for the digital therapeutics market

The digital therapeutics market is driven by affordable healthcare facilities available digitally, increasing use of mobile devices and rising integrated healthcare systems. Additionally, the prevalence of chronic diseases is rising due to expanding globalisation and changing lifestyles, including increased smoking, poor diet, inactivity, and drinking. Wearables and mobile devices are two of the major ongoing technical breakthroughs that create the infrastructure needed for the development and acceptance of digital therapeutics. Payers and employers are interested in digital therapeutics because of its cost-effectiveness in lowering healthcare costs.

Increasing number of patients suffering from chronic diseases

The increase in patients suffering from chronic diseases is one of the major factors fueling the digital therapeutics market growth. According to the National Centre for Chronic Disease Prevention and Health Promotion, 4 out of 10 adults in America have two or more chronic diseases, and 6 out of 10 Americans have at least one chronic illness. Moreover, Teladoc Health, Inc. introduced Chronic Care Complete in February 2022 as a revolutionary approach to comprehensive chronic condition management that promises to enhance patient outcomes. The major ailments in the nation that cause death and disability include cardiovascular conditions, cancer, diabetes, chronic kidney, lung, and Alzheimer's illnesses.

Launch of digital therapeutics mobile application

Launches of cutting-edge mobile applications for digital therapies are anticipated to fuel digital therapeutics market growth in the anticipated year. This growth is driven by major industry participants' focus on regulatory body approvals. In addition, smartphones, smart medical devices, and cloud-based data platforms have made better treatment and health monitoring possible. These factors contribute to the expanding global digital therapeutics market share.

Rising adoption of digital therapeutics solutions is anticipated to drive the market

The adoption of digital therapeutics solutions is anticipated to grow along with the level of digitalization in healthcare. For instance, according to an announcement made by DynamiCare Health Inc. in February 2022, the DCH-001, a digital treatment for tobacco use disorder complicating pregnancy and childbirth, received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA). In addition, the FDA claims that digital therapeutic solutions, assist consumers in making decisions about their health that are more informed.

Growing inclination towards digital health

Digital health tools are revolutionising consumer health and self-care by supporting consumers across many different health sectors which is anticipated to drive the digital therapeutics market. These technologies already provide support to consumers in several different health domains. Self-care digital health treatments are particularly well adapted to areas including diet and nutrition, lifestyle and stress management, fitness, mental health, women's health, pain management, and sleep. Furthermore, consumers can actively manage their health with the use of digital health tools in various fields by utilising cutting-edge technologies, data-driven insights, and user-friendly interfaces, which improve outcomes and boost satisfaction.

North America is anticipated to dominate the digital therapeutics market

North America's digital therapeutics market is anticipated to expand significantly throughout the forecast period as a result of favourable reimbursement scenarios that emphasize better tracking and diagnosis as well as enhanced quality of life due to the greater use of digital health goods. Additionally, strategic actions done by major businesses in this region, like new product launches and mergers & acquisitions, are anticipated to drive the market growth

Major market players focus on product innovation

Digital therapeutics market share is predicted to grow as a result of an increase in the number of improvements made to reduce the U.S. healthcare system's rising costs and a greater emphasis on using a patient-centred healthcare model. For instance, the firm for managing chronic conditions using a smartphone, Kaia Health, closed a USD 75 million Series C fundraising round in April 2021. By providing improved options for treating and managing various ailments like diabetes, asthma, and obesity, the use of digital therapeutics is predicted to expand.

Product innovation is expected to further fuel the market

The enormous pipeline of potential medications anticipated to be released throughout the projection period is beneficial to the growth of the prescription digital therapeutics (PDTx) market. Digital Therapeutics also uses VR technology along with digital medications and applications. The technique has been in use for more than 20 years, although it is only used in a small number of conditions and specialised facilities. It has proven to be a crucial tool for giving exposure therapy for PTSD. Studies are also being conducted to see how well it might work for conditions like psychosis, addiction, obsessive-compulsive disorder (OCD), phobias, depression, anxiety, and eating disorders. Through simulation, the VR technology in DTx enables users to learn by going through real-world scenarios.

Market Key Developments

In February 2023, a proprietary application programming interface (API) developed exclusively for digital therapeutics (DTx) clinical trials was released by ObvioHealth.
In January 2023, Omada Health, Inc., a healthcare company that specialises in managing chronic conditions virtually, collaborated with Castell, an Intermountain Healthcare subsidiary that provides value-based care.
In September 2022, to perform a research examination on SparkRx, Limbix Health formed a partnership with Children's Hospital Los Angeles (CHLA). Teenagers who exhibit signs of depression in specific medical care settings may benefit from SparkRx as an additional medication.

Segmentation:

By Type

Devices
Software & Services

By Application

Diabetes
Obesity
CVD
Respiratory Diseases
Smoking Cessation
CNS Diseases
Others

By End-User

Patients
Providers
Payers
Employers
Others

By Geography

North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
Japan
China
India
South Korea
Indonesia
Thailand
Others

1. INTRODUCTION

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Data
2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Force Analysis
- 4.3.1. Bargaining Power of Suppliers
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. DIGITAL THERAPEUTICS MARKET, BY TYPE

5.1. Introduction
5.2. Devices
5.3. Software & Services

6. DIGITAL THERAPEUTICS MARKET, BY APPLICATION

6.1. Introduction
6.2. Diabetes
6.3. Obesity
6.4. CVD
6.5. Respiratory Diseases
6.6. Smoking Cessation
6.7. CNS Diseases
6.8. Others

7. DIGITAL THERAPEUTICS MARKET, BY END-USE

7.1. Introduction
7.2. Patients
7.3. Providers
7.4. Payers
7.5. Employers
7.6. Others

8. DIGITAL THERAPEUTICS MARKET, BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. United States
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. United Kingdom
- 8.4.2. Germany
- 8.4.3. France
- 8.4.4. Spain
- 8.4.5. Others
8.5. The Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Israel
- 8.5.4. Others
8.6. Asia Pacific
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others